Naturally occurring autoantibodies against alpha-Synuclein that inhibit the aggregation and cytotoxicity of alpha-Synuclein

Details for Australian Patent Application No. 2011222920 (hide)

Owner Dr. Rentschler Holding GmbH & Co. KG

Inventors Dodel, Richard; Bacher, Michael; Besong Agbo, Daniela; Hagemann, Sascha; Balzer-Geldsetzer, Monika; Rehberger, Bernd; Weber, Renee

Agent Davies Collison Cave

Pub. Number AU-A-2011222920

PCT Pub. Number WO2011/107544

Priority 10155373.3 03.03.10 EP

Filing date 3 March 2011

Wipo publication date 9 September 2011

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

20 September 2012 PCT application entered the National Phase

  PCT publication WO2011/107544 Priority application(s): WO2011/107544

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011222934-Drink can closure element

2011222910-Recombinant attenuated parvovirus